Delivery Order SPE2DB20D2002-SPE2DB24FL79B
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,605.41 firm fixed-price delivery order is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a completion date of February 5, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565214153 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a Delivery Order with a Firm Fixed Price of $1,062.78 and an ultimate completion date of July 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Department of Defense (DoD). The contract has a firm fixed price of $1,153.51 and an ultimate completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award, valued at $2,504.86, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order contract for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 500S, a medical pharmaceutical product, with a period of performance through April 30, 2024. The contract has a firm fixed price pricing type and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a ceiling value of $4,158.77 and a completion date of February 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract award, valued at $1,176.75, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 100S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it has an ultimate completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $15,804.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication, to support military treatment programs and facilities. The contract has a firm fixed-price pricing type and an ultimate completion date of September 10, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
The federal contract award, with ID SPE2DB22D2206|SPE2DB25FED63, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566373869 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a ceiling value of $13,159.87 and an ultimate completion date of November 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,842.12 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 6, 2025 and was awarded on February 5, 2025. This award is not designated as a set-aside contract....
This federal contract award is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,020.20 and is a Firm Fixed Price Delivery Order, with a period of performance ending on February 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen...